Using mouse models of Alzheimer’s, as well as human brain cells and tissue samples, the researchers showed that reducing PU.1 levels encourages microglia to express immune-regulating receptors typically found in lymphoid cells.
Related Posts
ICMR seeks industry tie-ups to develop indigenous therapy against Nipah virus
Post Views: 7 The Nipah virus (NiV), which has an…
Q2 healthcare & pharma deals drop to $1.3 billion
Post Views: 43 In Q2 2025, India’s healthcare and pharma sector…
NHRC notice to Health Ministry, FSSAI on ‘widespread reuse of cooking oil’
Post Views: 12 The National Human Rights Commission (NHRC) directed…